🔗 Share this article Prestigious Prize Recognizes Groundbreaking Immune System Research The prestigious award in Physiology or Medicine was awarded for transformative discoveries that clarify how the immune system attacks harmful infections while sparing the body's own cells. A trio of esteemed researchers—from Japan Prof. Sakaguchi and American experts Dr. Brunkow and Fred Ramsdell—share this accolade. Their work uncovered specialized "security guards" within the defense system that eliminate rogue immune cells capable of harming the organism. The discoveries are now paving the way for innovative therapies for autoimmune diseases and cancer. The winners will share a monetary award valued at 11m SEK. Crucial Findings "Their work has been essential for comprehending how the body's defenses functions and why we don't all develop severe autoimmune diseases," stated the head of the Nobel Committee. This trio's studies explain a core question: In what way does the defense system protect us from numerous invaders while keeping our healthy cells unharmed? The body's protection system uses white blood cells that scan for signs of disease, even pathogens and germs it has never encountered. These cells employ detectors—called recognition units—that are generated randomly in a vast number of variations. That gives the immune system the capacity to fight a wide array of threats, but the unpredictability of the process inevitably creates white blood cells that can target the host. Security Guards of the Immune System Researchers previously understood that a portion of these problematic defense cells were eliminated in the immune organ—the site where immune cells develop. The latest Nobel Prize recognizes the identification of regulatory T-cells—described as the body's "security guards"—which patrol the system to neutralize any immune cells that assault the healthy cells. We know that this mechanism fails in autoimmune diseases such as juvenile diabetes, MS, and RA. The prize committee stated, "The discoveries have established a novel area of investigation and accelerated the creation of new treatments, for example for cancer and immune disorders." In malignancies, T-regs block the body from attacking the growth, so research are aimed at lowering their numbers. In autoimmune diseases, experiments are testing increasing regulatory T-cells so the organism is not under attack. A similar method could also be useful in reducing the chances of organ transplant rejection. Pioneering Studies Professor Shimon Sakaguchi, of Osaka University, conducted experiments on rodents that had their immune gland removed, causing self-attack conditions. He showed that injecting immune cells from healthy animals could prevent the disease—suggesting there was a system for preventing defenders from harming the body. Mary Brunkow, affiliated with the Institute for Systems Biology in a US city, and Dr. Ramsdell, now at a biotech firm in a California city, were investigating an inherited immune disorder in mice and humans that led to the identification of a genetic factor critical for how regulatory T-cells function. "Their groundbreaking research has revealed how the immune system is controlled by T-reg cells, preventing it from mistakenly targeting the body's own tissues," commented a prominent physiology specialist. "This work is a remarkable illustration of how fundamental physiological research can have broad implications for public health."